CTI BioPharma Statistics
Total Valuation
Alexander's has a market cap or net worth of $1.25 billion. The enterprise value is $1.94 billion.
Important Dates
The next confirmed earnings date is Monday, August 4, 2025, before market open.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | Aug 11, 2025 |
Share Statistics
Alexander's has 5.11 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Current Share Class | 5.11M |
| Shares Outstanding | 5.11M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 16.14% |
| Owned by Institutions (%) | 64.97% |
| Float | 2.13M |
Valuation Ratios
The trailing PE ratio is 31.77 and the forward PE ratio is 45.06.
| Price/FFO Ratio | 17.18 |
| Price/AFFO Ratio | n/a |
| PE Ratio | 31.77 |
| Forward PE | 45.06 |
| PS Ratio | 5.73 |
| Forward PS | n/a |
| PB Ratio | 7.68 |
| P/TBV Ratio | 7.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 23.63 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 48.95 |
| EV / Sales | 8.83 |
| EV / EBITDA | 17.69 |
| EV / EBIT | 25.60 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 6.19.
| Current Ratio | 0.91 |
| Quick Ratio | 0.80 |
| Debt / Equity | 6.19 |
| Debt / EBITDA | 9.03 |
| Debt / FCF | n/a |
| Interest Coverage | 1.32 |
Financial Efficiency
Return on equity (ROE) is 20.16% and return on invested capital (ROIC) is 3.77%.
| Return on Equity (ROE) | 20.16% |
| Return on Assets (ROA) | 3.48% |
| Return on Invested Capital (ROIC) | 3.77% |
| Return on Capital Employed (ROCE) | 9.65% |
| Revenue Per Employee | $2.44M |
| Profits Per Employee | $440,522 |
| Employee Count | 90 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.22% in the last 52 weeks. The beta is 0.81, so Alexander's's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +1.22% |
| 50-Day Moving Average | 233.46 |
| 200-Day Moving Average | 215.88 |
| Relative Strength Index (RSI) | 52.80 |
| Average Volume (20 Days) | 53,653 |
Short Selling Information
The latest short interest is 122,158, so 2.39% of the outstanding shares have been sold short.
| Short Interest | 122,158 |
| Short Previous Month | 91,922 |
| Short % of Shares Out | 2.39% |
| Short % of Float | 5.75% |
| Short Ratio (days to cover) | 1.54 |
Income Statement
In the last 12 months, Alexander's had revenue of $219.89 million and earned $39.65 million in profits. Earnings per share was $7.72.
| Revenue | 219.89M |
| Gross Profit | 116.35M |
| Operating Income | 75.81M |
| Pretax Income | 51.53M |
| Net Income | 39.65M |
| EBITDA | 109.72M |
| EBIT | 75.81M |
| Earnings Per Share (EPS) | $7.72 |
Full Income StatementBalance Sheet
The company has $321.23 million in cash and $1.01 billion in debt, giving a net cash position of -$688.29 million or -$134.77 per share.
| Cash & Cash Equivalents | 321.23M |
| Total Debt | 1.01B |
| Net Cash | -688.29M |
| Net Cash Per Share | -$134.77 |
| Equity (Book Value) | 163.09M |
| Book Value Per Share | 31.93 |
| Working Capital | -51.86M |
Full Balance SheetCash Flow
| Operating Cash Flow | 53.00M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 52.91%, with operating and profit margins of 34.48% and 18.03%.
| Gross Margin | 52.91% |
| Operating Margin | 34.48% |
| Pretax Margin | 18.03% |
| Profit Margin | 18.03% |
| EBITDA Margin | 49.90% |
| EBIT Margin | 34.48% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $18.00, which amounts to a dividend yield of 7.17%.
| Dividend Per Share | $18.00 |
| Dividend Yield | 7.17% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 233.15% |
| Buyback Yield | -0.06% |
| Shareholder Yield | 7.28% |
| Earnings Yield | 3.17% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for Alexander's is $125.00, which is -49.03% lower than the current price. The consensus rating is "Sell".
| Price Target | $125.00 |
| Price Target Difference | -49.03% |
| Analyst Consensus | Sell |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
